BackHUTCHMED (China) Limited Overview
HUTCHMED (China) Limited - ADR

HUTCHMED (China) Limited Target Price

Analysts' average 12-month price target for HUTCHMED (China) Limited is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.26

Average Target Price

$13.8012.6% upside

2 analysts in the last 4 months

High: $14 | Low: $13.6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-23Goldman Sachs$1414.2% upsideOpen
2026-05-28Morgan Stanley$13.610.9% upsideOpen
2024-05-14Morgan StanleyJack Lin$17.542.7% upsideOpen

HUTCHMED (China) Limited (HCM) FAQ

As of the most recent data, HCM shows a target price of $14. Scroll down for historical charts and peer comparison views.

If HUTCHMED (China) Limited moved to the average analyst target of $14, shares would be roughly 12.6% higher than $12.26. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of HUTCHMED (China) Limited's earnings trajectory.

Besides this target price page, Stockcircle has HUTCHMED (China) Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $14) with ownership activity and broader fundamentals.

HUTCHMED (China) Limited's target price is $14; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.